RXRX vs RAPT
Comparison between Recursion Pharmaceuticals Inc - Class A (RXRX, Company) and RAPT Therapeutics Inc (RAPT, Company).
Both RXRX and RAPT are from the Healthcare sector.
5-Year PerformanceRAPT has outperformed RXRX, delivering a return of -14.6% compared to -38.8%
RXRX vs RAPT - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
RXRX vs RAPT - Historical Returns
Returns include dividend reinvestment.
RXRX vs RAPT - Annual Returns (2019 - 2026)
Returns include dividend reinvestment.
| Year | RXRX | RAPT |
|---|---|---|
| 2026 | -28.33% | +82.17% |
| 2025 | -43.27% | +159.74% |
| 2024 | -31.51% | -93.50% |
| 2023 | +30.60% | +33.53% |
| 2022 | -57.24% | -48.86% |
| 2021 | -45.27% | +81.47% |
| 2020 | N/A | -33.92% |
| 2019 | N/A | +112.38% |
RXRX vs RAPT Drawdown Comparison
The maximum drawdown for RXRX was -93.13%, occurring on Mar 30, 2026. This drawdown has not yet recovered.
The maximum drawdown for RAPT was -98.47%, occurring on May 13, 2025. This drawdown has not yet recovered.
The current RXRX drawdown is -92.72%. The current RAPT drawdown is -85.16%.
| Rank | RXRX | RAPT |
|---|---|---|
| #1 | -93.13% Jul 13, 2021 - Mar 30, 2026 | -98.47% Jan 27, 2020 - May 13, 2025 |
| #2 | -38.10% Apr 29, 2021 - Jun 17, 2021 | -36.69% Nov 8, 2019 - Nov 25, 2019 |
| #3 | -10.54% Apr 16, 2021 - Apr 21, 2021 | -26.43% Nov 25, 2019 - Dec 23, 2019 |
| #4 | -10.45% Jun 21, 2021 - Jul 6, 2021 | -13.65% Dec 24, 2019 - Jan 7, 2020 |
| #5 | -8.29% Apr 21, 2021 - Apr 29, 2021 | -11.35% Jan 17, 2020 - Jan 27, 2020 |
| #6 | N/A | -10.42% Jan 7, 2020 - Jan 14, 2020 |
| #7 | N/A | -5.38% Oct 31, 2019 - Nov 5, 2019 |
Correlation
Correlation between RXRX and RAPT is 0.64 which considered as a moderate positive correlation - the stocks show some tendency to move together.
Select Stocks to Compare
More Comparisons
Compare with similar stocks